USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Immunicon Corporation
Address:
Immunicon Corporation
3401 Masons Mill Rd, Ste 100
Huntingdon Valley, PA 19006
Phone:
(215) 830-0777
URL:
N/A
EIN:
232269490
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $250,000.00 5
SBIR Phase II $693,336.00 2
STTR Phase I $100,000.00 1
STTR Phase II $1,089,994.00 1

Award List:

FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Paul a. liberti , PRINCIPAL INVESTIGATOR
Abstract:
Feasibility studies for developing a novel clinical device are proposed. this device which would use immunological and complement reagents in conjunction with filtration and/or one or more magnetic retrieval systems to produce a new separation and collection technology could result in totally new… More

BIOPROCESSING CELLS FROM BLOOD USING BR-FF AND HGMS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Liberti, Paul A , Principal Investigator
Abstract:
The long term objective is to develop a new technology for industry scale affinity separations employing proprietary bio-receptor ferrofluids (br-ff) in combination with existing continuous high gradient magnetic separators (hgms) and improved systems currently being developed. br-ff are being used… More

BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Liberti, Paul A , Principal Investigator
Abstract:
N/a

BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$383,836.00
Agency:
HHS
Principal Investigator:
Liberti, Paul A , Principal Investigator
Abstract:
The long-term objective is to develop a new technology for industry scale affinity separations employing proprietary bio- receptor ferrofluids (br-ff) in combination with existing high gradient magnetic separators (hgms) and improved systems currently being developed. br-ff are being used… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Chandra Rao
Abstract:
N/a

Analysis of Circulating Cancer Cells Early in Disease

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Chandra Rao
Abstract:
DESCRIPTION: (provided by applicant) The long term objective of this proposal is commercialization of a test for the management of cancer. Immunicon has developed a sensitive test for detecting tumor cells in peripheral blood. … More

Analysis of Circulating Cancer Cells Early in Disease

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$309,500.00
Agency:
HHS
Principal Investigator:
Chandra Rao
Abstract:
DESCRIPTION: (provided by applicant) The long term objective of this proposal is commercialization of a test for the management of cancer. Immunicon has developed a sensitive test for detecting tumor cells in peripheral blood. … More

Gene Expression in Circulating Tumor Cells

Award Year / Program / Phase:
2003 / STTR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Research Institution:
FOX CHASE CANCER CENTER
RI Contact:
N/A
Abstract:
N/a